Location History:
- Zionsville, IN (US) (2009)
- Apex, NC (US) (2011)
Company Filing History:
Years Active: 2009-2011
Title: The Innovative Contributions of Charles A. Mihaliak
Introduction
Charles A. Mihaliak, a notable inventor based in Apex, North Carolina, has made significant strides in the fields of biotechnology and vaccine development. With a total of three patents to his name, Mihaliak's work has generative implications for agricultural and medical advancements.
Latest Patents
Among his latest patents, one notable invention is the "Preparation of vaccine master cell lines using recombinant plant suspension cultures." This innovative process involves a plant cell culture designed for producing proteinaceous agents. The plant cell line is stably transformed to express a transgene that encodes the desired protein. Importantly, it utilizes a growth medium that sustains the plant cell culture while preventing the growth of Mycoplasmataceae and is free of animal-derived materials. This streamlined approach facilitates continuous passaging, ensuring consistent transgene expression and the ability to recover transgene expression after cryopreservation.
Another prominent patent covers "Plant-made West Nile virus (WNV) vaccines, vectors and plant codon optimized sequences." This invention encompasses various compositions related to WNV polypeptides and their fragments, alongside polynucleotides, vectors, and transformed host cells essential for producing these polypeptides. The methods described in this patent are pivotal for generating immune responses and detecting WNV-specific or neutralizing antibodies.
Career Highlights
Throughout his career, Mihaliak has been associated with esteemed organizations such as Dow Agrosciences LLC and the United States of America, as represented by the Secretary of Agriculture. These roles have provided him with a platform to apply his innovative ideas in real-world contexts, contributing to advancements in scientific research and technology.
Collaborations
Mihaliak has also collaborated with several talented professionals in the field, including Matthew J. Fanton and Janis K. McMillen. These collaborations underline the significance of teamwork in advancing scientific innovation and the development of new technologies.
Conclusion
Charles A. Mihaliak's inventive contributions have established him as a key figure in biotechnology and vaccine research. His impressive portfolio of patents not only showcases his ingenuity but also highlights the potential for future advancements in health and agriculture. Through his work, Mihaliak continues to inspire innovation, paving the way for greater discoveries in the realm of science.